Ticker Details
EyePoint Pharmaceuticals, Inc. Common Stock
IPO Date:	February 1, 2005
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 3.72%
Avg Daily Range (30 D):	$0.26 | 1.94%
Avg Daily Range (90 D):	$0.44 | 3.05%

Institutional Daily Volume
Avg Daily Volume:	.33M
Avg Daily Volume (30 D):	.7M
Avg Daily Volume (90 D):	1.01M

Trade Size
Avg Trade Size (Sh.):	106
Avg Trade Size (Sh.) (30 D):	61
Avg Trade Size (Sh.) (90 D):	67

Institutional Trades
Total Institutional Trades:	1,039
Avg Institutional Trade:	$1.58M
Avg Institutional Trade (30 D):	$1.25M
Avg Institutional Trade (90 D):	$1.66M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.69M
Avg Closing Trade (30 D):	$1.26M
Avg Closing Trade (90 D):	$1.98M
Avg Closing Volume:	127.8K

News

May 19, 2026 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Na

May 6, 2026 @ 11:00 AM EyePoint Reports First Quarter 2026 Financial Resu... Source: Eyepoint, Inc.

Mar 16, 2026 @ 10:23 PM This Biotech Stock Up 700% Is Still a Top Holding ... Source: Jonathan Ponciano

Mar 16, 2026 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Na

Mar 15, 2026 @ 11:05 PM This Biotech Stock Up Nearly 100% in a Year Has Dr... Source: Jonathan Ponciano

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.99	$-.82	$-3.17
Diluted EPS	$-.99	$-.82	$-3.17
Revenue	$.7M	$.62M	$31.37M
Gross Profit
Net Income / Loss	$-84.83M	$-67.61M	$-231.96M
Operating Income / Loss	$-87.23M	$-70.35M	$-243.43M
Cost of Revenue
Net Cash Flow	$-24.11M	$27.24M	$2.12M
PE Ratio

Splits
Dec 09, 2020	1:10
Jun 11, 2008	1:4